Skip to main content
Top
Published in: Rheumatology International 8/2019

01-08-2019 | Ultrasound | Observational Research

Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study

Authors: Barbara Ruaro, Stefano Soldano, Vanessa Smith, Sabrina Paolino, Paola Contini, Paola Montagna, Carmen Pizzorni, Andrea Casabella, Samuele Tardito, Alberto Sulli, Maurizio Cutolo

Published in: Rheumatology International | Issue 8/2019

Login to get access

Abstract

The objective is to detect any possible correlation between the modified Rodnan skin score (mRSS) and dermal thickness (DT) measured by skin high-frequency ultrasound (US) and the percentage of circulating fibrocytes in patients with limited cutaneous systemic sclerosis (lcSSc). Eight lcSSc patients and five healthy subjects (control group, CNT) were enrolled. The skin involvement was evaluated by mRSS and US (18 and 22 MHz probes) in all 13 subjects in the 17 standard skin areas evaluated by mRss. Circulating fibrocytes were isolated from the peripheral blood mononuclear cells (PBMCs) of all lcSSc patients and the CNT group to analyze their percentage at baseline time (T0) when the experiments started with PBMCs’ isolation and collection and after 8 days of culture (T8). Non-parametric tests were used for the statistical analysis. A positive correlation between the percentage of circulating fibrocytes at T0, mRSS (p = 0.04 r = 0.96), and DT-US, evaluated by the 22 MHz and the 18 MHz probes (p = 0.03, r = 0.66 and p = 0.05, r = 0.52, respectively), was observed in lcSSc patients. Conversely, at T8, there was no correlation (p > 0.05) between these parameters in lcSSc group. In the CNT group, no correlations between mRSS or DT-US and the percentage of circulating fibrocytes were observed both at T0 and T8. The study shows the presence of a significant relationship between the percentage of circulating fibrocytes and DT, as evidenced by both mRSS and US, in limited cutaneus SSc. This observation may well suggest the reasonable hypothesis of a crucial contribution of circulating fibrocytes to skin fibrosis progression, which might be considered as further biomarkers.
Literature
1.
go back to reference Krieg T, Takehara K (2009) Skin disease: a cardinal feature of systemic sclerosis. Rheumatology 48:iii14–iii18CrossRefPubMed Krieg T, Takehara K (2009) Skin disease: a cardinal feature of systemic sclerosis. Rheumatology 48:iii14–iii18CrossRefPubMed
2.
go back to reference Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6:578–587CrossRefPubMed Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6:578–587CrossRefPubMed
3.
go back to reference van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed
4.
go back to reference Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
5.
go back to reference Kaldas M, Khanna PP, Furst DE et al (2009) Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis—assessment of individual body sites in two large randomized controlled trials. Rheumatology 48:1143–1146CrossRefPubMedPubMedCentral Kaldas M, Khanna PP, Furst DE et al (2009) Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis—assessment of individual body sites in two large randomized controlled trials. Rheumatology 48:1143–1146CrossRefPubMedPubMedCentral
6.
go back to reference Czirják L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE (2007) The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 66:966–969CrossRefPubMedPubMedCentral Czirják L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE (2007) The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 66:966–969CrossRefPubMedPubMedCentral
7.
go back to reference Kaloudi O, Bandinelli F, Filippucci E et al (2010) High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis 69:1140–1143CrossRefPubMed Kaloudi O, Bandinelli F, Filippucci E et al (2010) High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis 69:1140–1143CrossRefPubMed
8.
go back to reference Moore TL, Lunt M, McManus B, Anderson ME, Herrick AL (2003) Seventeen-point dermal ultrasound scoring system-a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology 42:1559–1563CrossRefPubMed Moore TL, Lunt M, McManus B, Anderson ME, Herrick AL (2003) Seventeen-point dermal ultrasound scoring system-a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology 42:1559–1563CrossRefPubMed
9.
go back to reference Sulli A, Ruaro B, Alessandri A et al (2014) Correlation between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis 73:247–251CrossRefPubMed Sulli A, Ruaro B, Alessandri A et al (2014) Correlation between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis 73:247–251CrossRefPubMed
11.
go back to reference Ruaro B, Sulli A, Pizzorni C et al (2018) Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients. Microvasc Res 115:28–33CrossRefPubMed Ruaro B, Sulli A, Pizzorni C et al (2018) Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients. Microvasc Res 115:28–33CrossRefPubMed
13.
go back to reference Eyden B (2008) The myofibroblasts: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 12:22–37CrossRefPubMed Eyden B (2008) The myofibroblasts: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 12:22–37CrossRefPubMed
14.
go back to reference Galligan CL, Fish EN (2013) The role of circulating fibrocytes in inflammation and autoimmunity. J Leukoc Biol 93:45–50CrossRefPubMed Galligan CL, Fish EN (2013) The role of circulating fibrocytes in inflammation and autoimmunity. J Leukoc Biol 93:45–50CrossRefPubMed
16.
go back to reference Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 86:1111–1118CrossRefPubMedPubMedCentral Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 86:1111–1118CrossRefPubMedPubMedCentral
17.
go back to reference Russo R, Medbury H, Guiffre A, Englert H, Manolios N (2007) Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol 26:1136–1141CrossRefPubMed Russo R, Medbury H, Guiffre A, Englert H, Manolios N (2007) Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol 26:1136–1141CrossRefPubMed
20.
go back to reference Zeng J, Guo LW (2018) Signaling mechanisms of myofibroblast activation: outside-in and inside-out. Cell Physiol Biochem 49:848–868CrossRef Zeng J, Guo LW (2018) Signaling mechanisms of myofibroblast activation: outside-in and inside-out. Cell Physiol Biochem 49:848–868CrossRef
22.
go back to reference Micallef L, Vedrenne N, Billet F, Coulomb B, Darby I, Desmoulière A (2012) The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 5(Suppl 1):S5PubMedPubMedCentral Micallef L, Vedrenne N, Billet F, Coulomb B, Darby I, Desmoulière A (2012) The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 5(Suppl 1):S5PubMedPubMedCentral
24.
go back to reference Just SA, Lindegaard H, Hejbøl EK et al (2017) Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in rheumatoid arthritis. Respir Res 18:141CrossRefPubMedPubMedCentral Just SA, Lindegaard H, Hejbøl EK et al (2017) Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in rheumatoid arthritis. Respir Res 18:141CrossRefPubMedPubMedCentral
25.
go back to reference Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562CrossRefPubMed Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562CrossRefPubMed
26.
go back to reference Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S (2005) Fibrocytes contribute to the myofibroblast population in the wounded skin and originate from the bone marrow. Exp Cell Res 304:81–90CrossRefPubMed Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S (2005) Fibrocytes contribute to the myofibroblast population in the wounded skin and originate from the bone marrow. Exp Cell Res 304:81–90CrossRefPubMed
28.
go back to reference Dupin I, Allard B, Ozier A et al (2016) Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR28-dependent pathway. J Allergy Clin Immunol 137:1036–1042CrossRefPubMed Dupin I, Allard B, Ozier A et al (2016) Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR28-dependent pathway. J Allergy Clin Immunol 137:1036–1042CrossRefPubMed
29.
go back to reference Cutolo M, Ruaro B, Montagna P et al (2018) Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Arthritis Res Therapy 20:77CrossRef Cutolo M, Ruaro B, Montagna P et al (2018) Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Arthritis Res Therapy 20:77CrossRef
30.
go back to reference Sulli A, Soldano S, Pizzorni C et al (2009) Raynaud’s phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 36:1235–1239CrossRefPubMed Sulli A, Soldano S, Pizzorni C et al (2009) Raynaud’s phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 36:1235–1239CrossRefPubMed
31.
go back to reference Dupin I, Allard B, Ozier A et al (2016) Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR31-dependent pathway. J Allergy Clin Immunol 137:1036–1042CrossRefPubMed Dupin I, Allard B, Ozier A et al (2016) Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR31-dependent pathway. J Allergy Clin Immunol 137:1036–1042CrossRefPubMed
32.
go back to reference Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
33.
go back to reference Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67:885–887CrossRefPubMed Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67:885–887CrossRefPubMed
34.
go back to reference Pizzorni C, Sulli A, Smith V et al (2017) Primary Raynaud’s phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. Clin Rheumatol 36:1637–1642CrossRefPubMed Pizzorni C, Sulli A, Smith V et al (2017) Primary Raynaud’s phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. Clin Rheumatol 36:1637–1642CrossRefPubMed
35.
go back to reference Ruaro B, Casabella A, Paolino S et al (2018) Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). Clin Rheumatol 37:3057–3062CrossRefPubMed Ruaro B, Casabella A, Paolino S et al (2018) Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). Clin Rheumatol 37:3057–3062CrossRefPubMed
36.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods 25:402–408CrossRefPubMed
39.
go back to reference Sun M, Wang P, Okubo T et al (2018) Possible contribution of fibrocytes to increased type i collagen synthesis during the early stage of dermal wound repair in human skin. J Invest Dermatol 138:240–242CrossRefPubMed Sun M, Wang P, Okubo T et al (2018) Possible contribution of fibrocytes to increased type i collagen synthesis during the early stage of dermal wound repair in human skin. J Invest Dermatol 138:240–242CrossRefPubMed
40.
go back to reference Bagnato G, Harari S (2015) Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24:102–114CrossRefPubMed Bagnato G, Harari S (2015) Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24:102–114CrossRefPubMed
41.
go back to reference Moore BB, Kolodsick JE, Thannickal VJ et al (2005) CCR41-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166:675–684CrossRefPubMedPubMedCentral Moore BB, Kolodsick JE, Thannickal VJ et al (2005) CCR41-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166:675–684CrossRefPubMedPubMedCentral
42.
go back to reference Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesys of pulmonary fibrosis. J Leukoc Biol 86:1111–1118CrossRefPubMedPubMedCentral Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesys of pulmonary fibrosis. J Leukoc Biol 86:1111–1118CrossRefPubMedPubMedCentral
43.
go back to reference Keeley EC, Mehrad B, Strieter RM (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 101:613–618CrossRefPubMedPubMedCentral Keeley EC, Mehrad B, Strieter RM (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 101:613–618CrossRefPubMedPubMedCentral
44.
go back to reference Phillips RJ, Burdick MD, Hong K et al (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438–446CrossRefPubMedPubMedCentral Phillips RJ, Burdick MD, Hong K et al (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438–446CrossRefPubMedPubMedCentral
45.
46.
Metadata
Title
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study
Authors
Barbara Ruaro
Stefano Soldano
Vanessa Smith
Sabrina Paolino
Paola Contini
Paola Montagna
Carmen Pizzorni
Andrea Casabella
Samuele Tardito
Alberto Sulli
Maurizio Cutolo
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04315-7

Other articles of this Issue 8/2019

Rheumatology International 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.